ENG/中
老虎证券
市场
行情
24/7新闻
产品
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
三倍做多标普生物-Direxion
172.00
-15.5800
-8.31%
盘后:
174.40
2.40
+1.40%
19:59 EST
成交量:
38.23万
成交额:
6,877.39万
市值:
4.43亿
市盈率:
- -
高:
192.79
开:
181.88
低:
171.02
收:
187.58
52周最高:
341.93
52周最低:
131.75
股本:
257.45万
流通股本:
257.45万
量比:
1.00
换手率:
14.85%
股息:
0.92
股息率:
0.53%
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
美国众议院民主党领袖杰弗里斯:医疗保健是民主党可能与特朗普合作的领域之一。
智通财经
·
昨天
Sirtex收购FDA许可Hourglass落地,远大医药(00512)精准介入生态协同实力再升级
智通财经
·
昨天
世界数据组织医疗健康专业委员会在京启动运行
智通财经
·
11/21
医疗保健行业综述:市场动态
投资观察
·
11/21
年销数百亿美元的“减肥神药”陷致盲风波
中国经营网
·
11/21
美国总统特朗普:我对优秀的医疗保健持开放态度。
格隆汇
·
11/21
医疗保健板块综述:市场观察
投资观察
·
11/21
诺和诺德的诺泽优 ®获美国 FDA 批准,成为首个且唯一用于特纳综合征患儿的每周一次长效生长激素。
智通财经
·
11/21
BELITE BIO股价下跌14.5%,因FDA延长对眼病药物的审查。
智通财经
·
11/20
SAVARA:FDA对SAVARA的莫格司亭生物制品许可申请的审查正在进行中;未提供修订后的行动日期。
智通财经
·
11/20
稷山县医疗保障局国家税务总局稷山县税务局关于企业依法为职工参加职工基本医疗保险的告知书
市场资讯
·
11/20
世界数据组织医疗健康专业委员会启动运行
智通财经
·
11/20
津药药业:倍他米松原料药获FDA DMF First Adequate Letter
智通财经
·
11/20
江西宜春:社区养老 情暖夕阳
环球网
·
11/20
维立志博-B于Jefferies全球医疗健康大会发布维利信最新临床及安全性数据
财中社
·
11/20
医疗保健行业综述:市场观察
投资观察
·
11/20
美国钢铁公司:临时协议确保美国钢铁公司的工资增长、医疗保健和设施投资。
智通财经
·
11/19
异动解读|三倍做多标普生物-Direxion盘中上涨5.63%,生物医药审批与研发进展提振板块
行情直击
·
11/19
阿斯利康胃癌疗法获美国FDA授予优先审评资格
格隆汇
·
11/19
强生申请美国FDA批准卡普莱塔用于治疗双相情感障碍躁狂发作。
智通财经
·
11/19
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/LABU/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"三倍做多标普生物-Direxion","latestPrice":172,"timestamp":1795208400000,"preClose":187.58,"halted":0,"volume":382330,"hourTrading":{"tag":"盘后","latestPrice":174.4,"preClose":172,"latestTime":"19:59 EST","volume":4421,"amount":771112.1053,"timestamp":1795222773836,"change":2.4,"changeRate":0.013953,"amplitude":0.032166},"delay":0,"changeRate":-0.08305789529800625,"floatShares":2574486,"shares":2574486,"eps":0,"marketStatus":"休市中","change":-15.58,"latestTime":"11-20 16:00:00 EST","open":181.88,"high":192.79,"low":171.02,"amount":68773891.26009999,"amplitude":0.116057,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1795424400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":187.58,"sharesOutstanding":3074486,"nav":172.311,"aum":434995921.04,"dividendRate":0.005344,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":182.01,"preClose":187.58,"latestTime":"09:29 EST","volume":4211,"amount":775343.55318,"timestamp":1795184996955,"change":-5.57,"changeRate":-0.029694,"amplitude":0.029216},"postHourTrading":{"tag":"盘后","latestPrice":174.4,"preClose":172,"latestTime":"19:59 EST","volume":4421,"amount":771112.1053,"timestamp":1795222773836,"change":2.4,"changeRate":0.013953,"amplitude":0.032166},"volumeRatio":1.0005987895186548,"impliedVol":1.2466,"impliedVolPercentile":0.9841},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2574486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0005987895186548,"shares":2574486,"dividePrice":0.9191,"high":192.79,"amplitude":0.116057,"preClose":187.58,"low":171.02,"week52Low":131.75,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":172,"eps":0,"divideRate":0.005344,"volume":382330,"delay":0,"ttmEps":0,"open":181.88,"prevYearClose":159.39,"prevWeekClose":214.83,"prevMonthClose":247.22,"prevQuarterClose":265.79,"fiveDayClose":214.83,"twentyDayClose":219.6,"sixtyDayClose":331.23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2685314334","title":"美国众议院民主党领袖杰弗里斯:医疗保健是民主党可能与特朗普合作的领域之一。","url":"https://stock-news.laohu8.com/highlight/detail?id=2685314334","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2685314334?lang=zh_cn&edition=fundamental","pubTime":"2026-11-22 23:52","pubTimestamp":1795362771,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["VHT","XBI","BK4585","BK4550","BK4581","NOBL","XLV","BK4588","CGVV","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2685411758","title":"Sirtex收购FDA许可Hourglass落地,远大医药(00512)精准介入生态协同实力再升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2685411758","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2685411758?lang=zh_cn&edition=fundamental","pubTime":"2026-11-22 17:39","pubTimestamp":1795340384,"startTime":"0","endTime":"0","summary":"拉长时间轴来看,Hourglass的纳入只是远大医药核药抗肿瘤诊疗及心脑血管精准介入诊疗科技领域持续扩容的最新一步。栓塞新品补位介入管线,精准诊疗平台协同扩容Hourglass的并入有望与易甘泰形成实质性的流程协同。纳入Hourglass后,远大医药有望进一步覆盖“术前侧支封堵+术中肿瘤内放射”的一站式解决方案,将两款产品从各自独立的器械,串联为同一手术流程中的连续环节。更长远来看,Hourglass的适应症边界也意味着新的市场空间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1526794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","LABU","BK1191","00512","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2685498194","title":"世界数据组织医疗健康专业委员会在京启动运行","url":"https://stock-news.laohu8.com/highlight/detail?id=2685498194","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2685498194?lang=zh_cn&edition=fundamental","pubTime":"2026-11-21 16:37","pubTimestamp":1795250262,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4588","IXJ","XLV","XBI","VHT","BK4550","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182002158","title":"医疗保健行业综述:市场动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1182002158","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182002158?lang=zh_cn&edition=fundamental","pubTime":"2026-11-21 05:54","pubTimestamp":1795211650,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场动态。彭博周四报道称,赛诺菲正在考虑收购Insmed。赛诺菲在道琼斯通讯社联系时拒绝置评,Insmed也未回应置评请求。Jefferies表示,尽管收购Insmed可能跻身近年来最大的生物制药交易之列,但对赛诺菲而言并非遥不可及。分析师称,赛诺菲的收购预算可能超过250亿欧元,而按照典型的交易溢价计算,收购Insmed将耗资约310亿欧元。赛诺菲股价上涨1.7%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","LABU","XLV","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2685621461","title":"年销数百亿美元的“减肥神药”陷致盲风波","url":"https://stock-news.laohu8.com/highlight/detail?id=2685621461","media":"中国经营网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2685621461?lang=zh_cn&edition=fundamental","pubTime":"2026-11-21 03:57","pubTimestamp":1795204674,"startTime":"0","endTime":"0","summary":"近日,美国FDA发布通告称,使用GLP-1RAs(GLP-1受体激动剂类)产品可能增加非动脉性前缺血性视神经病变(NAION)的风险。NAION是一种罕见的疾病,可能导致单眼急性、无痛、视力下降,包括永久性视力丧失。美国FDA要求所有GLP-1RAs药物的申请持有人在标签上增加风险警示信息。这一消息在社交媒体平台上引起广泛热议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611213936566972.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611213936566972.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["JDOC","BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2685645171","title":"美国总统特朗普:我对优秀的医疗保健持开放态度。","url":"https://stock-news.laohu8.com/highlight/detail?id=2685645171","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2685645171?lang=zh_cn&edition=fundamental","pubTime":"2026-11-21 02:31","pubTimestamp":1795199507,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LABU","XBI","BK4585","NOBL","XLV","VHT","BK4588","CGVV","BK4581","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115173955","title":"医疗保健板块综述:市场观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1115173955","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115173955?lang=zh_cn&edition=fundamental","pubTime":"2026-11-21 01:25","pubTimestamp":1795195506,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场观察。以下内容仅在道琼斯通讯社发布。赛诺菲在被道琼斯通讯社联系时拒绝置评,Insmed也未回应置评请求。1441 ET - Anthropic股价远高于其IPO发行价,但市场其余板块正在抛售,从新型云服务板块到健康保险均表现疲软。联合健康集团下滑4.6%,此前周三已暴跌10%,因政府本周早些时候承诺打击Medicare Advantage欺诈行为,且议员们再次呼吁实施全民医保。道琼斯工业平均指数下跌1.7%,标普500指数下跌1.4%,纳斯达克指数下滑1.6%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XBI","BK4585","XLV","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2685169515","title":"诺和诺德的诺泽优 ®获美国 FDA 批准,成为首个且唯一用于特纳综合征患儿的每周一次长效生长激素。","url":"https://stock-news.laohu8.com/highlight/detail?id=2685169515","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2685169515?lang=zh_cn&edition=fundamental","pubTime":"2026-11-21 00:48","pubTimestamp":1795193318,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA","BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684163594","title":"BELITE BIO股价下跌14.5%,因FDA延长对眼病药物的审查。","url":"https://stock-news.laohu8.com/highlight/detail?id=2684163594","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684163594?lang=zh_cn&edition=fundamental","pubTime":"2026-11-20 22:35","pubTimestamp":1795185330,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684150647","title":"SAVARA:FDA对SAVARA的莫格司亭生物制品许可申请的审查正在进行中;未提供修订后的行动日期。","url":"https://stock-news.laohu8.com/highlight/detail?id=2684150647","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684150647?lang=zh_cn&edition=fundamental","pubTime":"2026-11-20 21:30","pubTimestamp":1795181450,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684154401","title":"稷山县医疗保障局国家税务总局稷山县税务局关于企业依法为职工参加职工基本医疗保险的告知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2684154401","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684154401?lang=zh_cn&edition=fundamental","pubTime":"2026-11-20 19:49","pubTimestamp":1795175340,"startTime":"0","endTime":"0","summary":"职工医保由单位、个人按规定比例共同缴费,按月向税务部门申报缴纳。对自查发现的问题立即整改,及时为未参保职工办理参保登记,补缴欠费、更正人员信息,全面完成自纠工作,并留存自查整改记录备查。主动向职工宣传医疗保险相关政策,及时告知职工本人参保缴费情况,妥善回应职工关于医保参保的咨询诉求,构建和谐用工关系。业务咨询可联系属地医保经办机构、税务办税服务厅。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-11-20/doc-inizkurf0303095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","XLV","BK4588","159891","LABU","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684131203","title":"世界数据组织医疗健康专业委员会启动运行","url":"https://stock-news.laohu8.com/highlight/detail?id=2684131203","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684131203?lang=zh_cn&edition=fundamental","pubTime":"2026-11-20 16:10","pubTimestamp":1795162255,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","LABU","XLV","BK4585","BK4581","IXJ","VHT","BK4550","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684139058","title":"津药药业:倍他米松原料药获FDA DMF First Adequate Letter","url":"https://stock-news.laohu8.com/highlight/detail?id=2684139058","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684139058?lang=zh_cn&edition=fundamental","pubTime":"2026-11-20 15:44","pubTimestamp":1795160642,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","LABU","BK4585","DMF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684584184","title":"江西宜春:社区养老 情暖夕阳","url":"https://stock-news.laohu8.com/highlight/detail?id=2684584184","media":"环球网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684584184?lang=zh_cn&edition=fundamental","pubTime":"2026-11-20 10:14","pubTimestamp":1795140840,"startTime":"0","endTime":"0","summary":"新华社记者 胡晨欢 摄11月19日,宜春市袁州区“如夏园享老社区”的老年居民在打门球。近年来,江西省宜春市袁州区将社区居家养老列为民生改革重点,通过提供就餐入住、医疗保健等服务,让老人们乐享晚年。截至2026年10月,袁州区已建成45家城市社区居家养老服务中心,121个农村互助养老服务中心。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-11-20/doc-inizixmn4050121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["VHT","BK4550","XBI","LABU","BK4588","BK4585","XLV","NOBL","BK4581","YUNG","CGVV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684918938","title":"维立志博-B于Jefferies全球医疗健康大会发布维利信最新临床及安全性数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2684918938","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684918938?lang=zh_cn&edition=fundamental","pubTime":"2026-11-20 08:43","pubTimestamp":1795135380,"startTime":"0","endTime":"0","summary":"11月20日,维立志博-B(09887)发布公告,宣布公司创始人、董事长兼首席执行官康小强博士于2026年11月19日出席2026Jefferies全球医疗健康大会,发表了关于公司自主研发的维利信?(奥帕替苏米单抗,抗PD-L1/4-1BB双特异性抗体)的最新临床及安全性数据。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611203935784983.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611203935784983.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","HK0000252160.HKD","XLV","HK0000252152.HKD","XBI","HK0000500386.USD","BK1161","BK4581","09887","IXJ","LABU","VHT","BK4588","159760","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164159081","title":"医疗保健行业综述:市场观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1164159081","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164159081?lang=zh_cn&edition=fundamental","pubTime":"2026-11-20 01:22","pubTimestamp":1795108951,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场观察汇总。0444 ET - 摩根大通分析师在一份研究报告中表示,诺华制药发布截至2031年的最新销售指引,很可能推动市场对该瑞士药企的共识预期上修。摩根大通称,基于诺华2026年预计录得的565.7亿美元销售额,其新指引意味着2031年销售将达711.1亿美元。他们补充道,假设2031年核心营业利润率为40%,诺华核心营业利润将达284.5亿美元,与共识预测一致。该团队表示,这一需求预计将延续至2027年第一季度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4585","BK4588","XLV","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684916908","title":"美国钢铁公司:临时协议确保美国钢铁公司的工资增长、医疗保健和设施投资。","url":"https://stock-news.laohu8.com/highlight/detail?id=2684916908","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684916908?lang=zh_cn&edition=fundamental","pubTime":"2026-11-19 23:28","pubTimestamp":1795102100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4581","BK4585","XBI","XLV","LABU","VHT","NOBL","BK4550","BK4588","CGVV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191271429","title":"异动解读|三倍做多标普生物-Direxion盘中上涨5.63%,生物医药审批与研发进展提振板块","url":"https://stock-news.laohu8.com/highlight/detail?id=1191271429","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191271429?lang=zh_cn&edition=fundamental","pubTime":"2026-11-19 23:09","pubTimestamp":1795100941,"startTime":"0","endTime":"0","summary":"11月19日,三倍做多标普生物-Direxion盘中上涨5.63%,报201.605美元,成交额4729.17万美元。消息面上,生物医药板块当日迎来多项监管与研发进展,带动做多型杠杆ETF走强。此外,阿斯利康胃癌药sonesitatug vedotin获FDA优先审评,Hutchmed的sovleplenib获孤儿药资格,行业内密集利好强化了市场对生物科技与创新药资产的风险偏好。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"生物医药利好密集,做多型杠杆ETF走强","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684977875","title":"阿斯利康胃癌疗法获美国FDA授予优先审评资格","url":"https://stock-news.laohu8.com/highlight/detail?id=2684977875","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684977875?lang=zh_cn&edition=fundamental","pubTime":"2026-11-19 22:19","pubTimestamp":1795097982,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684971308","title":"强生申请美国FDA批准卡普莱塔用于治疗双相情感障碍躁狂发作。","url":"https://stock-news.laohu8.com/highlight/detail?id=2684971308","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684971308?lang=zh_cn&edition=fundamental","pubTime":"2026-11-19 21:02","pubTimestamp":1795093347,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GDOC","LU0070217475.USD","IYH","LU2129689431.USD","LU1244550494.USD","IE00BVYPNV92.GBP","LU1506573853.SGD","LU0072461881.USD","JDOC","BMED","LU0820561818.USD","IE00B19Z3581.USD","BK4504","LU1914381329.SGD","IHE","XLV","LU2129689514.USD","LU2456880835.USD","BK4592","LU1066053197.SGD","FHLC","JNJ","LU1935042991.SGD","LU2213496289.HKD","IE0002141913.USD","LABU","IE000SO60NU8.SGD","LU0912757837.SGD","TRUH","IXJ","LU0787776722.HKD","LU0795875086.SGD","LU1929549753.HKD","MEDX","IE00B4R5TH58.HKD","PJP","RXL","LU0289961442.SGD","LU2430703178.SGD","LU1057294990.SGD","LU1228905540.USD","LU0964807845.USD","BK4581","LU2430703251.USD","LU2403377893.USD","FTXH","LU0545039389.USD","VHT","LU2487616109.SGD","LU0553294199.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}